Maximilian Burger

Active 2007–2026

94
Papers
21,098
Citations
56
h-index
84
i10-index

Citations

Citations per year for Maximilian Burger2001: 3 citations2003: 1 citations2007: 4 citations2008: 9 citations2009: 28 citations2010: 28 citations2011: 62 citations2012: 67 citations2013: 77 citations2014: 104 citations2015: 93 citations2016: 118 citations2017: 117 citations2018: 133 citations2019: 715 citations2020: 835 citations2021: 778 citations2022: 609 citations2023: 419 citations2024: 693 citations2025: 247 citations2026: 15 citations2002: no citations, so this year is not shown2004–2006: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,114 citing papers, 15.3% of this breakdownChina: 991 citing papers, 13.6% of this breakdownItaly: 515 citing papers, 7.1% of this breakdownGermany: 489 citing papers, 6.7% of this breakdownUnited Kingdom: 348 citing papers, 4.8% of this breakdownFrance: 333 citing papers, 4.6% of this breakdownNetherlands: 314 citing papers, 4.3% of this breakdownJapan: 289 citing papers, 4% of this breakdownAustria: 287 citing papers, 3.9% of this breakdownCanada: 275 citing papers, 3.8% of this breakdownSpain: 266 citing papers, 3.7% of this breakdownSwitzerland: 166 citing papers, 2.3% of this breakdown
0%15.3%Other 25.9%

Fields

  • Medicine78.5%
  • Biochemistry, Genetics and Molecular Biology15.5%
  • Immunology and Microbiology2.1%
  • Engineering1.8%
  • Computer Science0.7%
  • Environmental Science0.2%
  • Other1.2%

Topics

  • Bladder and Urothelial Cancer Treatments24.4%
  • Urinary and Genital Oncology Studies12.5%
  • Ferroptosis and cancer prognosis3.5%
  • Cancer Immunotherapy and Biomarkers2.9%
  • Epigenetics and DNA Methylation2.8%
  • Urinary Tract Infections Management1.9%
  • Other52%

Coauthors

All papers

Open in search
  1. European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ)

    Authors: , , , , , , , , , , , , , , , , - European Urology 2021 cited by 1,623

  2. Bladder cancer

    Authors: , , , , , , - Nature Reviews Disease Primers 2017 cited by 822

  3. Epidemiology and Risk Factors of Urothelial Bladder Cancer

    Authors: , , , , , , , , , , - European Urology 2012 cited by 2,187

  4. European Association of Urology (EAU) Prognostic Factor Risk Groups for Non–muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Andrea Haitel, Jean‐François Côté, Soha El Sheikh, Luca Lunelli, Ferrán Algaba, Isabel Alemany, Francesco Soria, Willemien Runneboom, Johannes Breyer, Jakko A. Nieuwenhuijzen, Carlos Llorente, Luca Molinaro, Christina A. Hulsbergen‐van de Kaa, Matthias Evert, Lambertus A. Kiemeney, James N’Dow, Karin Plass, Otakar Čapoun, Viktor Soukup, José L. Domínguez-Escrig, Daniel L. Cohen, Joan Palou, Paolo Gontero, Maximilian Burger, Richard Zigeuner, Amir Hugh Mostafid, Shahrokh F. Shariat, Morgan Rouprêt, Éva Compérat, Marko Babjuk, Bas W.G. van Rhijn - European Urology 2021 cited by 463

  5. European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update

    Authors: , , , , , , , , , , , , , , , , , - European Urology 2019 cited by 1,327

  6. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 Update

    Authors: , , , , , , , , , , , , , , , , , - European Urology 2020 cited by 941

  7. EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016

    Authors: , , , , , , , , , , , , , , - European Urology 2016 cited by 2,298

  8. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update

    Authors: , , , , , , , , , , , - European Urology 2015 cited by 1,344

  9. Recurrence and Progression of Disease in Non–Muscle-Invasive Bladder Cancer: From Epidemiology to Treatment Strategy

    Authors: , , , , , , , - European Urology 2009 cited by 760

  10. The Tumor Immune Microenvironment Drives a Prognostic Relevance That Correlates with Bladder Cancer Subtypes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Immunology Research 2019 cited by 232

  11. Prognostic Value of the WHO1973 and WHO2004/2016 Classification Systems for Grade in Primary Ta/T1 Non–muscle-invasive Bladder Cancer: A Multicenter European Association of Urology Non–muscle-invasive Bladder Cancer Guidelines Panel Study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Diana Turturica, Francesca Pisano, Francesco Soria, Otakar Čapoun, Lenka Bauerová, Michael Pešl, H.M. Bruins, Willemien Runneboom, Sonja Herdegen, Johannes Breyer, A. Brisuda, Ana Calatrava, J. Rubio‐Briones, Maximilian Seles, Sebastian Mannweiler, Judith Bosschieter, V.R.M. Kusuma, David Ashabere, Nicolai Huebner, Juliette Cotte, Laura S. Mertens, Daniel L. Cohen, Luca Lunelli, Olivier Cussenot, Soha El Sheikh, Dimitrios Volanis, Jean‐François Côté, Morgan Rouprêt, Andrea Haitel, Shahrokh F. Shariat, Hugh Mostafid, Jakko A. Nieuwenhuijzen, Richard Zigeuner, José L. Domínguez-Escrig, Jaromír Háček, Alexandre R. Zlotta, Maximilian Burger, Matthias Evert, Christina A. Hulsbergen ‐ van de Kaa, Antoine G. van der Heijden, Lambertus A. Kiemeney, Viktor Soukup, Luca Molinaro, Paolo Gontero, Carlos Llorente, Ferrán Algaba, Joan Palou, James N’Dow, Theodorus van der Kwast, Marko Babjuk, Richard J. Sylvester - European Urology Oncology 2021 cited by 101

  12. EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013

    Authors: , , , , , , , , , , - European Urology 2013 cited by 1,175

  13. How does artificial intelligence master urological board examinations? A comparative analysis of different Large Language Models’ accuracy and reliability in the 2022 In-Service Assessment of the European Board of Urology

    Authors: , , , , , , , - World Journal of Urology 2024 cited by 31

  14. Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-muscle Invasive Bladder Cancer Guidelines Panel

    Authors: , , , , , , , , , , , , , , , , - European Urology 2016 cited by 318

  15. Photodynamic Diagnosis of Non–muscle-invasive Bladder Cancer with Hexaminolevulinate Cystoscopy: A Meta-analysis of Detection and Recurrence Based on Raw Data

    Authors: , , , , , , , , , , , , , - European Urology 2013 cited by 450

  16. FGFR3 Mutation Status and FGFR3 Expression in a Large Bladder Cancer Cohort Treated by Radical Cystectomy: Implications for Anti-FGFR3 Treatment?†

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Núria Malats, Arndt Hartmann, Yves Allory, Tahlita C.M. Zuiverloon - European Urology 2020 cited by 89

  17. Prognostic Factors in Upper Urinary Tract Urothelial Carcinomas: A Comprehensive Review of the Current Literature

    Authors: , , , , , , , , - European Urology 2012 cited by 431

  18. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update

    Authors: , , , , , , , , , , , - European Urology 2017 cited by 770

  19. Oncological Outcomes of Laparoscopic Nephroureterectomy Versus Open Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: An European Association of Urology Guidelines Systematic Review

    Authors: , , , , , , , , , , , , , , , , , , - European Urology Focus 2017 cited by 156

  20. C-reactive protein flare predicts response to anti-PD-(L)1 immune checkpoint blockade in metastatic urothelial carcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - European Journal of Cancer 2022 cited by 36

  21. Definition and Diagnosis of Oligometastatic Bladder Cancer: A Delphi Consensus Study Endorsed by the European Association of Urology, European Society for Radiotherapy and Oncology, and European Society of Medical Oncology Genitourinary Faculty

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Peter Hoskin - European Urology 2023 cited by 33

  22. Potential Benefit of Lymph Node Dissection During Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the European Association of Urology Guidelines Panel on Non–muscle-invasive Bladder Cancer

    Authors: , , , , , , , , , , , , , , , , , , - European Urology Focus 2017 cited by 129

  23. Performance of the Food and Drug Administration/EMA-approved programmed cell death ligand-1 assays in urothelial carcinoma with emphasis on therapy stratification for first-line use of atezolizumab and pembrolizumab

    Authors: , , , , , , , , , , , , , , , , , , , , , - European Journal of Cancer 2018 cited by 103

  24. Hexaminolevulinate Guided Fluorescence Cystoscopy Reduces Recurrence in Patients With Nonmuscle Invasive Bladder Cancer

    Authors: , , , , , , , , , - The Journal of Urology 2010 cited by 302